Lancet Market Size, Research, Analysis

1
Global Lancet Market to Grow at a CAGR of 12
During 2022 2031 on the Account of Increasing
Population Worldwide Kenneth Research published
a report titled Lancet Market Global Demand
Analysis Opportunity Outlook 2031 which
delivers detailed overview of the global lancet
market in terms of market segmentation by type,
application, end users, and by region. Further,
for the in-depth analysis, the report encompasses
the industry growth indicators, restraints,
supply and demand risk, along with detailed
discussion on current and future market trends
that are associated with the growth of the
market. The global lancet market is garnered an
approximate revenue figure of USD 1125 million
in year 2021 and is estimated to grow at a CAGR
of 12 over the forecast period, i.e., 2022
2031. On the basis of application segment, the
market is further divided into glucose testing,
hemoglobin testing, and coagulation testing. The
glucose testing segment is anticipated to grow
at a promising CAGR over the forecast period on
the back of growing diabetes incidences,
accurate results of glucose testing, and no
account of side effects.
2
Lancets are small finger-pricking devices that
helps in obtaining blood samples without any
hassle. The growth of the global lancet market
can be associated with the growing incidences of
chronic diseases such as diabetes, as well as
high prevalence of infectious diseases.
Moreover, advancement in healthcare
infrastructure, increasing patient pool, and
better provision for reimbursement policies are
anticipated to boost the growth of the
market. On the basis of region, the global lancet
market is segmented into five major regions
including North America, Europe, Asia Pacific,
Latin America, and Middle East Africa region.
Even though North America presented the maximum
growth in the year 2021, the market in Asia
Pacific is estimated to show significant growth
over the forecast period. The growth of the
market can be attributed to the rising cases of
chronic disease and growing patient population
in the region. Moreover, the advancement in
healthcare infrastructure and support
initiatives taken by government are also expected
to drive the market growth. The research is
global in nature and covers detailed analysis on
the market in North America (U.S., Canada),
Europe (U.K., Germany, France, Italy, Spain,
Hungary, Belgium, Netherlands Luxembourg,
NORDIC Finland, Sweden, Norway, Denmark,
Poland, Turkey, Russia, Rest of Europe), Latin
America (Brazil, Mexico, Argentina, Rest of
Latin America), Asia-Pacific (China, India,
Japan, South Korea, Indonesia, Singapore,
Malaysia, Australia, New Zealand, Rest of
Asia-Pacific), Middle East and Africa (Israel,
GCC Saudi Arabia, UAE, Bahrain, Kuwait, Qatar,
Oman, North Africa, South Africa, Rest of
Middle East and Africa). In addition, analysis
comprising market size, Y-O-Y growth
opportunity analysis, market players competitive
study, investment opportunities, demand for
future outlook etc. has also been covered and
displayed in the research report. Request sample
report https//www.kennethresearch.com/sample-
request-10094822 Growing Prevalence of Diabetes
to Boost the Growth of Global Lancet Market
3
As per the American Diabetes Association, 37.3
million people had diabetes in the year 2019.
The patients suffering from diabetes are required
to monitor their blood sugar level on a daily
basis, hence they account to the largest
population base for using lancets. In the other
statistics sourced from the American Diabetes
Association, 1.4 million new diabetes cases are
recorded every year. Hence, the growing
prevalence of diabetes is anticipated to act as
a major factor to the growth of the global lancet
market during the forecast period. However,
rising cases of needlestick injury, and high risk
of infection at homecare settings are expected
to operate as key restraint to the growth of
global lancet market over the forecast
period. This report also provides the existing
competitive scenario of some of the key players
of the global lancet market which includes
company profiling F. Hoffmann-La Roche Ltd.,
Becton, Dickinson and Company, SARSTEDT AG Co.
KG, Tenko Medical Systems Corp, HTL-STREFA (MTD
Medical Technology and Devices S.A), Terumo
Corporation, Ypsomed AG, Owen Mumford Limited,
ARKRAY, Inc., Bayer AG, and others. The
profiling enfolds key information of the
companies which encompasses business overview,
products and services, key financials and recent
news and developments. On the whole, the report
depicts detailed overview of the global lancet
market that will help industry consultants,
equipment manufacturers, existing players
searching for expansion opportunities, new
players searching possibilities and other
stakeholders to align their market centric
strategies according to the ongoing and expected
trends in the future. Request sample report
https//www.kennethresearch.com/sample-
request-10094822 Kenneth Research is a leading
service provider for strategic market research
and consulting. We aim to provide unbiased,
unparalleled market insights and industry
analysis to help industries, conglomerates and
executives to take wise decisions for their
future marketing strategy, expansion and
investment etc. We believe every business can
expand to its new horizon, provided a right
guidance at a right time is available through
4
strategic minds. Our out of box thinking helps
our clients to take wise decision in order to
avoid future uncertainties. Contact for more
Info AJ Daniel Email sales_at_kennethresearch.com
U.S. Phone [phone]